2′,3′-dideoxyadenosine is a purine 2′,3′-dideoxyribonucleoside in which the nucleobase component is specified as adenine. It has a role as an EC 4.6.1.1 (adenylate cyclase) inhibitor and an EC 3.5.4.4 (adenosine deaminase) inhibitor. It is a purine 2′,3′-dideoxyribonucleoside and a member of adenosines.

Its key purpose lies within combatting diverse viral infections, emblematically those instigated by the herpes family. By thwarting viral DNA synthesis, this compound proficiently hampers the replication of these intrusive pathogens. The astute amalgamation of an exceptional chemical framework and an intricately orchestrated mechanism efficaciously endows this entity with an unparalleled potential to counteract a […]

7-Deaza-2′,3′-dideoxy-7-iodoguanosine, a compound of significant importance in the biomedical sector, possesses remarkable capacities to selectively combat various ailments, predominantly viral infections, through hindering viral replication. Its multifaceted antiviral properties pave the way for potential breakthroughs in viral infection treatment. Augmenting therapeutic outcomes in preclinical investigations, this substance exhibits immense promise when administered in conjunction with […]

7-Deaza-2′,3′-dideoxy-7-iodoadenosine is an exceedingly potent antiviral compound, extensively employed to study specific viral afflictions, predominantly triggered by RNA viruses. By selectively zeroing in on the viral polymerase and curtailing the compoundion of viral RNA, this pharmaceutical compound obstructs viral replication flawlessly.

5-iodotubercidin is an organoiodine compound. It is functionally related to a tubercidin.

7-Deaza-2′-deoxy-7-iodoguanosine is a potent antiviral compound used in biomedicine. It exhibits antiviral activity against Herpes Simplex Virus (HSV) and Varicella-Zoster Virus (VZV). This nucleoside analogue acts by inhibiting viral DNA synthesis, making it effective in the treatment of HSV and VZV infections. It is commonly used in research and drug development related to antiviral therapies.

It is a derivative of 7-Iodo-7-deazadenine and is designed to be incorporated into DNA by using Vent(exo-) polymerase primers extension.

It is a Rho-GTPase cell protein inhibitor.

5-Iodocytidine is an intermediate for research in the field of nucleic acids and nucleic acid-protein interactions.

5-Iodo-2′-deoxyuridine is a nucleoside analog treat herpes simplex keratitis.